Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
PROTAC-induced proteolytic targetingKimberly Cornish Carmony, Kyung-Bo KimCell Biochemistry and Biophysics|May 24, 2013
Activity-based imaging probes of the proteasomeKimberly Cornish Carmony, Kyung Bo KimChembiochem : a European Journal of Chemical Biology|December 6, 2014
Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probesKimberly Cornish Carmony, Lalit Kumar Sharma, Do-Min Lee, et al.Bioorganic & Medicinal Chemistry|July 12, 2011
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probesKimberly Cornish Carmony, Do-Min Lee, Ying Wu, et al.Molecular Biosystems|December 5, 2013
A FRET-based approach for identification of proteasome catalytic subunit compositionJi Eun Park, Ying Wu, Kimberly Cornish Carmony, et al.Molecular Biosystems|June 23, 2012
Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathwayEun Ryoung Jang, Na-Ra Lee, Songhee Han, et al.Cancer Drug Resistance (Alhambra, Calif.)|July 26, 2021
Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?Kyung Bo KimCurrent Topics in Medicinal Chemistry|August 10, 2011
The immunoproteasome: an emerging therapeutic targetWooin Lee, Kyung Bo KimNatural Product Reports|April 12, 2013
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomesKyung Bo Kim, Craig M CrewsCurrent Cancer Drug Targets|July 26, 2014
The immunoproteasome as a therapeutic target for hematological malignanciesZachary Miller, Wooin Lee, Kyung Bo KimPageof 7